Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer

Copenhagen University Hospital at Herlev

Status: Completed

Conditions: Prostatic Neoplasms

Study type: Observational

Funder types: Other

Identifiers

NCT01441713

HeH.750.19-25

Details and patient eligibility

About

Patients with advanced prostate cancer usually receive some kind of pharmaceutical castration or undergo surgical castration. At the investigators department the pharmaceutical treatment is most often given with a 3 month interval.

Over the last few years new drugs, which allow for lees frequent treatment, have been developed. The purpose of this study is to assess how the treatment affects patients and if our current patients would prefer to receive treatment at different intervals than they do at the present time. At the same time the investigators will assess how surgical treatment affects our patients. This will be assessed by patient questionnaires administered at our clinic.

Enrollment: 178 patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• A diagnosis of advanced prostate cancer
• Receiving hormone manipulation treatment (pharmaceutical castration) OR having undergone surgical castration (orchiectomy)

Exclusion criteria

• Inability to read/write Danish

Trial design

178 participants in 2 patient groups

Pharmaceutical group

Description:

Patients in pharmaceutical castration treatment for advanced prostate cancer

Surgical group

Description:

Patients having undergone surgical castration treatment for advanced prostate cancer